Literature DB >> 27136

Pharmacokinetics of Erythromycin in man.

J T Wilson, C J van Boxtel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 27136

Source DB:  PubMed          Journal:  Antibiot Chemother (1971)        ISSN： 0066-4758


× No keyword cloud information.
  8 in total

Review 1.  Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II).

Authors:  P Periti; T Mazzei; E Mini; A Novelli
Journal:  Clin Pharmacokinet       Date:  1989-05       Impact factor: 6.447

2.  Gynaecological tissue levels of azithromycin.

Authors:  K Krohn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-10       Impact factor: 3.267

3.  Synthesis and antibacterial activity of a novel class of 15-membered macrolide antibiotics, "11a-azalides".

Authors:  Tomohiro Sugimoto; Tetsuya Tanikawa
Journal:  ACS Med Chem Lett       Date:  2010-12-30       Impact factor: 4.345

4.  Enprofylline disposition in the presence and absence of amoxycillin or erythromycin.

Authors:  D S Sitar; F Y Aoki; D J Hoban; K G Hidinger; P R Montgomery; P A Mitenko
Journal:  Br J Clin Pharmacol       Date:  1987-07       Impact factor: 4.335

Review 5.  The new macrolides. Azithromycin and clarithromycin.

Authors:  M S Kanatani; B J Guglielmo
Journal:  West J Med       Date:  1994-01

6.  Intersubject and dose-related variability after intravenous administration of erythromycin.

Authors:  K L Austin; L E Mather; C R Philpot; P J McDonald
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

7.  Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution.

Authors:  A E Girard; D Girard; A R English; T D Gootz; C R Cimochowski; J A Faiella; S L Haskell; J A Retsema
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

8.  Absorption and bioavailability of oral erythromycin.

Authors:  L E Mather; K L Austin; C R Philpot; P J McDonald
Journal:  Br J Clin Pharmacol       Date:  1981-08       Impact factor: 4.335
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.